Fibromyalgia/CFS/ME Treatments Lounge
88 Members
Created by Michelle Hamilton

View Article

Ads on Cymbalta for Fibromyalgia Called Misleading

January 22nd, 2010 by Michelle Hamilton


Sunday January 17, 2010

NEWSBRIEF: An FDA letter calls Eli Lilly's print ads for Cymbalta (duloxetine) as a fibromyalgia treatment misleading.

The letter says a magazine ad doesn't adequately convey the risks of taking the drug. Risk information was on an adjacent page but not in the body of the ad, which the FDA calls a "misleading presentation."

The letter also takes issue with an ad aimed at doctors, which it says overstates the drug's effectiveness and minimizes risks. Again, risk information was separated from efficacy claims.

Cymbalta was approved as a fibromyalgia treatment in June 2008. It's a serotonin-norepinephrine reuptake inhibitor (SNRI) aimed at correcting the neurotransmitter dysregulation associated with the condition. To date, it's one of only 3 drugs approved for fibromyalgia.

Tagged
Results 1 - 1

  • Lynnette

    All 3 of these drugs have benefits to fibros if taken correctly. People get caught up in the phrase "approved for use for fibromyalgia". That does not mean a cure, or it erases all the symptoms. It means it has been proven to be beneficial for treating some fibromyalgia related pain, or symptoms. Messing with your norepinephrine can be dangerous. This is a chemical in the brain that is also used for a life saving rescue drug to increase blood pressure in patients who are septic or have had a trauma. When in use that way it is a drug we use with great caution. These new meds increase the availability of norepinephrine for you body to use. They can help. I like the med savella, but at a way lower dose than my doctor was aiming for.



    Presentation by drug companies will always be one thing. A company trying to make money. Do your homework. Come here and let us help you sort through the difficult stuff. That's what we are here for.

    24 months ago

Sign In to leave a comment.